Curanex Pharmaceuticals Inc Common Stock

CURX XNAS PHARMACEUTICAL PREPARATIONS

Market Cap

5.3M

Short interest (Jul 15)

0.0%

Net Short (Jul 27 ): 0.0%

Borrow Fee

21.12%

Available Shares

300K

Price Chart

Company Overview

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

Company Info

Exchange: NASDAQ
Industry: PHARMACEUTICAL PREPARATIONS
CIK: 0002025942
Asset Type: CS

Market Data

Market Cap: $5,329,748
Employees: 6
Status: Active

Short Interest

Current Borrow Fee 21.12%
Range: 21.12% - 21.12%
Available Shares 300K
Range: 80K - 250K

Recent Changes

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime